Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02628899 · ClinicalTrials.gov registry record · NA
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
A NA study of Aortic Stenosis, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 277
- Enrollment target
- 11
- Study locations
NCT02628899 is a NA study of Aortic Stenosis that has completed, run by Medstar Health Research Institute. The registered enrollment target is 277 participants, below the 1,352-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (80% lower). The trial reports 11 study locations across 9 states.
The verdict
NCT02628899, a NA study of Aortic Stenosis, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 277 participants
- Enrollment target
- 11
- Study locations
Study Summary
To assess the safety and feasibility of Transcatheter Aortic Valve Replacement (TAVR) with commercially available bioprostheses in patients with severe, symptomatic aortic stenosis (AS) who are low-risk (STS score ≤3%) for surgical aortic valve replacement (SAVR).
Conditions Studied
Interventions
- DEVICE SAVR
- DEVICE Transfemoral TAVR
Study Locations (11)
California
- Sutter Health System - Sacramento
- Foundation for Cardiovascular Medicine - San Diego
Virginia
- Henrico Doctors' Hospital - Richmond
- VCU Medical Center - Richmond
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Georgia
- WellStar Kennestone Hospital - Marietta
Maine
- Maine Medical Center - Portland
New Jersey
- The Valley Hospital - Ridgewood
New York
- Stony Brook Hospital - Stony Brook
Oklahoma
- St. John Health System - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2016-01 |
| Est. Completion | 2023-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02628899
The ClinicalTrials.gov registry entry for NCT02628899 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 277 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,352-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (80% lower). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Stenosis appearing as the primary indexed condition, and to 2 interventions - of which SAVR is the first listed.
NCT02628899 reports 11 study locations spanning 9 distinct geographic areas - top geographies include California, Virginia, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT02628899 about?
NCT02628899 is a clinical study titled "Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis". To assess the safety and feasibility of Transcatheter Aortic Valve Replacement (TAVR) with commercially available bioprostheses in patients with severe, symptomatic aortic stenosis (AS) who are low-risk (STS score ≤3%) for surgical aortic valve replacement (SAVR).
What is the current status of trial NCT02628899?
This trial is currently completed. It is a NA study. The enrollment target is 277 participants. The study started on 2016-01. Estimated completion is 2023-01.
What conditions does trial NCT02628899 study?
This clinical trial studies the following conditions: Aortic Stenosis.
What interventions are being tested in trial NCT02628899?
The interventions under investigation include: SAVR (DEVICE), Transfemoral TAVR (DEVICE).
Who is sponsoring clinical trial NCT02628899?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02628899 being conducted?
This trial has 11 study locations across California, District of Columbia, Georgia, Maine, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
RECRUITING · NA
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
-
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
RECRUITING · NA
-
PARTNER 3 Trial - Aortic Valve-in-Valve
RECRUITING · NA
-
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
RECRUITING · NA
-
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.